Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Enovis Corporation Common Stock (NY:ENOV)

22.07 +0.44 (+2.03%)
Official Closing Price Updated: 4:10 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Enovis Corporation Common Stock

News headline image
Enovis Announces Planned CEO Succession Process
From Enovis Corporation
Via GlobeNewswire
News headline image
Earnings Scheduled For February 26, 2025 ↗
 
Via Benzinga
News headline image
Enovis (ENOV) Q4 Earnings: What To Expect
Medical technology company Enovis Corporation (NYSE:ENOV) will be announcing earnings results tomorrow before market open. Here’s what to expect. 
Via StockStory
News headline image
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
From Enovis Corporation
Via GlobeNewswire
News headline image
The Latest Analyst Ratings For Enovis ↗
 
Via Benzinga
News headline image
Critical Insights From Enovis Analyst Ratings: What You Need To Know ↗
 
Via Benzinga
News headline image
A Closer Look at 6 Analyst Recommendations For Enovis ↗
 
Via Benzinga
News headline image
Enovis™ Announces Leadership Change to International Surgical Business
From Enovis Corporation
Via GlobeNewswire
News headline image
Instacart Grows Stronger: S&P MidCap 400 Inclusion, Ulta Partnership Boosts Stock ↗
Instacart gains as it is set to join S&P MidCap 400. The company also partners with Ulta Beauty for same-day delivery, boosting stock value. 
Via Benzinga
Topics Stocks
News headline image
Instacart Stock Jumps. It'll Join The S&P MidCap 400 Index. ↗
The grocery delivery company will soon join the S&P MidCap 400 index. 
Via Investor's Business Daily
Topics Stocks
News headline image
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis Announces Third Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Host Third Quarter 2024 Results Conference Call on November 6th
From Enovis Corporation
Via GlobeNewswire
News headline image
Orthopedic Implant Player Enovis' M&A Strategy Core To Growth And Competitiveness, Analyst Says ↗
JMP Securities initiates coverage on Enovis Corporation with a Market Outperform rating, highlighting its strategic acquisitions, including LimaCorporate, and future growth potential. The analyst notes... 
Via Benzinga
News headline image
Enovis Appoints Tim Czartoski as President, U.S. Surgical and Global Product and Enabling Technologies
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis™ Introduces the Next Generation of Foot and Ankle Surgery Offerings at AOFAS Annual Meeting
With the upcoming launch of the innovative Tarsoplasty solution and live demonstrations of the Better Step patient-focused platform, Enovis™ Foot & Ankle continues to drive its portfolio into “The Fast... 
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis Continues to Redefine Revision Knee Surgery with the Addition of EMPOWR™ Cones to EMPOWR Revision Knee™, Creating a Comprehensive Portfolio for Efficient Revision Procedures
First surgeries using EMPOWR Revision Knee™ with EMPOWR™ Cones successfully completed by design consultants Dr. Beau Kildow and Dr. Leonard T. Buller. 
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis™ Introduces STAR® Ankle, now with e+™ Polyethylene for Unmatched Durability
Revolutionary Scandinavian Total Ankle Replacement (STAR® Ankle) System Now Includes Vitamin E-Blended Polyethylene Insert 
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
News headline image
ENOV Stock Earnings: Enovis Beats EPS, Misses Revenue for Q2 2024 ↗
ENOV stock results show that Enovis beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Enovis Announces Second Quarter 2024 Results
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis Announces Time Change for Second Quarter 2024 Results Conference Call
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis to Host Second Quarter 2024 Results Conference Call on August 7th
From Enovis Corporation
Via GlobeNewswire
News headline image
Enovis™ Releases AltiVate Reverse® Glenoid System, Widening Range of Patients Who May be Treated with AltiVate Reverse®
New full-range solution adds bone-sparing baseplate, peripheral fixation, and glenosphere options to proven reverse shoulder prosthesis (RSP®) glenoid baseplate while maintaining hallmark simplicity... 
From Enovis Corporation
Via GlobeNewswire
News headline image
Top 3 Health Care Stocks That Could Blast Off In June ↗
 
Via Benzinga
News headline image
5 Medical Info Systems Stocks To Buy For Stable Returns ↗
The medical info systems industry is thriving due to the growing demand for contactless services. Amid this environment, here are some stocks in the industry that may see stable returns in 2024. 
Via Talk Markets
News headline image
Enovis to Participate in Upcoming Investor Conferences
From Enovis Corporation
Via GlobeNewswire
News headline image
Top 4 Health Care Stocks Which Could Rescue Your Portfolio This Month ↗
 
Via Benzinga
News headline image
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024 ↗
ENOV stock results show that Enovis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.